Clinical-stage biotechnology company
Appears in 1 story
Raised $324 million; preparing first FDA drug filing
IDEAYA Biosciences closed a $323.6 million stock sale on June 10, 2026. The cash lands as the company prepares to file its first drug with the U.S. Food and Drug Administration (FDA).
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
